Asuragen
Austin
About Asuragen
Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen's current diagnostics product portfolio consists of Signature® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $80.0M
- Funding stage: M&A
- Last round: Series Unknown (Mar 2013)
- Website: asuragen.com
- Phone: 5126815201
Industries & Categories
Biotechnology, Genetics, Health Diagnostics, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/asuragen-2457535 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.